Breast cancer screening guidelines in the US are under scrutiny due to concerns about costs, follow-up tests, and disparities in screening recommendations.
The new US Preventive Services Task Force (USPSTF) recommendation to start routine mammography screening at age 40 for women at average risk lacks strong evidence and may lead to more harm than benefit.